1. Home
  2. IRON vs NRP Comparison

IRON vs NRP Comparison

Compare IRON & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • NRP
  • Stock Information
  • Founded
  • IRON 2017
  • NRP 2002
  • Country
  • IRON United States
  • NRP United States
  • Employees
  • IRON N/A
  • NRP N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • NRP Coal Mining
  • Sector
  • IRON Health Care
  • NRP Energy
  • Exchange
  • IRON Nasdaq
  • NRP Nasdaq
  • Market Cap
  • IRON 1.4B
  • NRP 1.3B
  • IPO Year
  • IRON N/A
  • NRP N/A
  • Fundamental
  • Price
  • IRON $44.24
  • NRP $96.00
  • Analyst Decision
  • IRON Strong Buy
  • NRP
  • Analyst Count
  • IRON 10
  • NRP 0
  • Target Price
  • IRON $83.80
  • NRP N/A
  • AVG Volume (30 Days)
  • IRON 397.9K
  • NRP 17.0K
  • Earning Date
  • IRON 05-07-2025
  • NRP 05-06-2025
  • Dividend Yield
  • IRON N/A
  • NRP 4.40%
  • EPS Growth
  • IRON N/A
  • NRP N/A
  • EPS
  • IRON N/A
  • NRP 10.46
  • Revenue
  • IRON N/A
  • NRP $229,909,000.00
  • Revenue This Year
  • IRON N/A
  • NRP N/A
  • Revenue Next Year
  • IRON N/A
  • NRP N/A
  • P/E Ratio
  • IRON N/A
  • NRP $9.37
  • Revenue Growth
  • IRON N/A
  • NRP N/A
  • 52 Week Low
  • IRON $28.25
  • NRP $81.74
  • 52 Week High
  • IRON $68.73
  • NRP $113.04
  • Technical
  • Relative Strength Index (RSI)
  • IRON 45.99
  • NRP 41.49
  • Support Level
  • IRON $40.36
  • NRP $95.79
  • Resistance Level
  • IRON $47.21
  • NRP $104.99
  • Average True Range (ATR)
  • IRON 2.87
  • NRP 3.40
  • MACD
  • IRON 0.10
  • NRP -0.47
  • Stochastic Oscillator
  • IRON 37.67
  • NRP 6.01

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.

Share on Social Networks: